Microservices Architecture Regulatory Publishing Azure: Scale Fast

The Cost of All-in-One Regulatory Publishing Systems

Regulatory teams know this scenario all too well: your submission deadline is three weeks away, but your publishing system buckles under the load of several dossiers at once. Your IT team estimates two days to recover. Meanwhile, your FDA filing sits incomplete, potentially delaying an approval by months.

Traditional publishing platforms are built as a single block of software, and that creates dangerous bottlenecks. When one part fails, everything fails. When you need to add requirements for a new market, you are looking at months of development and a risky update to the whole system. These limitations are not just inconvenient—they are compliance risks that can derail submissions and delay patient access to treatments.

This is why the DnXT Publisher Suite is built the opposite way: as a set of independent services running on Azure, each doing one job. Breaking regulatory work into separate, independently scalable parts removes single points of failure and shortens time to market.

Who This Is For

This approach addresses specific pain points across regulated organisations:

• VP Regulatory Affairs — needs submission speed without compromising compliance across global markets
• Regulatory Publishing Managers — drowning in manual eCTD assembly and PDF formatting across multiple therapeutic areas
• Quality Assurance Directors — concerned about maintaining complete audit trails during system failures or updates
• CRO Project Managers — scaling publishing operations across dozens of sponsor clients with different requirements
• IT Directors in Life Sciences — balancing regulatory compliance demands with modern security and scalability requirements

How It Works

The platform runs as a set of independent parts, each responsible for one stage of the work:

1. Signing in: Single sign-on through your existing corporate directory routes people to the right areas based on their role and their organisation.
2. Bringing documents in: Connects to the document systems you already use — Veeva Vault, Documentum, SharePoint — and routes documents to the right place for processing.
3. Checking: Structure checks, PDF compliance and metadata validation run on their own, without slowing anything else down.
4. AI assistance: Analyses document content, extracts regulatory information, and flags likely submission problems before they reach a reviewer.
5. Managing the process: Handles status changes, approval routing and notifications, while keeping the complete audit trail 21 CFR Part 11 requires.
6. Assembling the submission: Produces the final eCTD package, coordinating PDF rendering and table of contents so the formatting meets regulatory requirements.
7. Recording everything: A dedicated audit capability captures every interaction across all of the above, giving inspectors a complete history.

Key Benefits

• Updates without downtime: Individual parts are updated on their own, without interrupting work in progress. Your team keeps working on an urgent filing while improvements go live in the background.
• Capacity that follows demand: Azure automatically adds capacity to whichever part is busy. During peak submission periods, the checking capability grows while everything else stays as it is.
• Problems stay contained: If PDF rendering has trouble, document review and approval carry on uninterrupted. One failure does not cascade into a general outage.
• Faster response to new requirements: New regulatory requirements — an updated Health Canada specification, say — are delivered as a change to one part, which means less to retest and a faster route to compliance.
• Separation between clients: Each client’s data is kept completely separate while sharing the underlying infrastructure, which is what makes this cost-effective for a CRO managing many sponsors.
• Complete auditability: Detailed audit records provide inspectors with visibility into every document interaction, supporting FDA inspection readiness and SOC 2 requirements.

Real-World Impact

The improvements deliver measurable business value:

One major pharmaceutical client reduced their NDA submission preparation time from 12 weeks to 6 weeks, directly attributable to being able to work on several things at once and to eliminating downtime during critical deadlines.

Why It Matters for Regulatory Teams

FDA guidance increasingly emphasises robust quality systems and data integrity in regulatory submissions. Building the platform from independent parts supports both, by ensuring that no single failure can compromise the integrity of a submission or leave a gap in the audit trail.

Emerging requirements — EMA’s structured data initiatives, FDA’s Real-World Evidence guidelines — demand a flexibility that all-in-one systems simply cannot provide. Regulatory teams need to adapt quickly to changing requirements without a major system overhaul each time.

This also supports the industry’s move towards continuous engagement with health authorities. Teams can maintain ongoing correspondence while preparing formal submissions, knowing the platform will cope with the increased workload.

Get Started

Ready to remove publishing bottlenecks and shorten your submission timelines? The DnXT Publisher Suite is helping pharmaceutical companies worldwide reduce submission preparation time while maintaining the highest compliance standards.

Contact our regulatory technology specialists to arrange a demonstration: https://www.dnxtsolutions.com/contacts/